Relationship between fluoropyrimidine (FPD) exposure and outcomes in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial.
| Autor: | Fakih, Marwan, Prager, Gerald W., Taieb, Julien, Calleja, Elizabeth Martine, Liu, Mei, Amellal, Nadia, Tabernero, Josep |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p114-114, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|